Article
What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?
Journal of hepatology - 1 Feb 2015
McDonald Scott A, Innes Hamish A, Hayes Peter C, Dillon John F, Mills Peter R, Goldberg David J, Barclay Stephen, Allen Sam, Fox Ray, Fraser Andrew, Kennedy Nicholas, Bhattacharyya Diptendu, Hutchinson Sharon J
Abstract excerpt
BACKGROUND & AIMS: The global burden associated with hepatitis C virus (HCV) infection has prompted a scale-up of antiviral therapy. Hitherto, no data exist on the impact of scaling-up, on the characteristics of treated populations, or on sustained viral response (SVR) rates. We assessed the country-wide scale-up of antiviral therapy in Scotland, a country which nationally monitors uptake of and response to HCV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
